Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303

John M. Goldberg, MD

Pediatric Oncology Consortium

John M. Goldberg, is an Assistant Professor of Clinical Pediatrics and Director of the Pediatric Oncology Early Phase Clinical Trials Program at the University of Miami Sylvester Comprehensive Cancer. His research focuses on the translation of laboratory discoveries into new therapies for patients. Dr. Goldberg’s particular interests include immunotherapy, new treatments for leukemia, lymphoma, sarcoma, brain tumors,and the development of HDAC inhibitors for children with cancer. He trained at the Dana-Farber Cancer Institute in the laboratory of David E. Fisher, where he developed a background in molecular oncology, and carried out immunotherapy and targeted trials with the adult melanoma and sarcoma groups.


Robert G. Maki, MD, PhD, FACP

Pediatric Oncology and Sarcoma Consortium

Robert Maki is Professor in the Departments of Medicine and Orthopaedics, and also Section Chief in Pediatric Hematology-Oncology at Tisch Cancer Institute, Mt Sinai Medical Center in New York. He trained at Dana Farber Cancer Center and worked there as well as becoming Section Chief of the Adult Sarcoma Division at MSKCC with an Appointment as Associate Professor at Cornell University, Weill Medical College.

POC_Capabilities

Download Capability Slide
Oncology Consortium | All Rights Reserved 2012-2017
Back to Top